
Growth-Accommodating Medtech: How Expandable Scaffolds Disrupt Congenital Surgical Cycles
Dr. Dereck Mush, MD, MBANo. 0 Founders & operators
CEO, Edwards Lifesciences • United States
Leads the world’s largest structural heart valve company through its next phase of growth.
Find on LinkedInAs chief executive of Edwards Lifesciences, Zovighian sets direction for transcatheter heart valve therapy, one of the most important device categories in modern cardiology, and speaks regularly on patient access and innovation.
Leads the world’s largest structural heart valve company through its next phase of growth.
As chief executive of Edwards Lifesciences, Zovighian sets direction for transcatheter heart valve therapy, one of the most important device categories in modern cardiology, and speaks regularly on patient access and innovation.
Loading the full dossier
Audience size across LinkedIn, X, YouTube, podcasts and newsletters.
How much the audience actually reacts, comments, shares and subscribes.
Clinical, research, operating or investing track record behind the commentary.
Publishing cadence and how reliably they show up with original work.
Whether decision makers, policy and capital actually move on what they say.
Scores are subjective editorial estimates compiled by our research desk from public profiles and published work. They are opinion, not measurement, and they are not a judgement of any person's character or ability.
Change, add or remove details on this profile. Our desk reviews every request.
This profile is compiled by our research desk from public sources and is published as editorial commentary. Want a correction, an update, or your profile removed? and see our corrections and removals policy.

Dr. Dereck Mush, MD, MBAKeep exploring